Paralog-selective ligands for Bcl-2 proteins

被引:56
作者
Gemperli, AC
Rutledge, SE
Maranda, A
Schepartz, A
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[2] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA
关键词
D O I
10.1021/ja0441211
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
There is considerable current interest in molecules that bind intra- or extracellular protein surfaces and inhibit protein-protein interactions. Previously we have reported that miniature proteins based on pancreatic-fold polypeptides can recognize even shallow α-helix binding clefts with high affinity and selectivity against unrelated proteins. One such miniature protein, PPBH3-1, binds the anti-apoptotic protein paralogs Bcl-2 and Bcl-XL with nanomolar affinity and a ΔΔG = 1.2 kcal·mol-1 preference for Bcl-XL. Here we describe the directed evolution of PPBH3-1 into two new miniature proteins, PPBH3-5 and PPBH3-6, whose paralog specificity is reversed relative to PPBH3-1. PPBH3-5 and PPBH3-6 bind Bcl-2 with nanomolar affinity and a ΔΔG = 0.9-1.3 kcal·mol-1 preference for Bcl-2 over Bcl-XL. Experiments with Bcl-XL variants suggest that PPBH3-5 and PPBH3-6 achieve high paralog specificity by exploiting subtle structural or electrostatic differences in the Bcl-2 and Bcl-XL molecular landscapes. PPBH3-5 and PPBH3-6 may have unique applications as early examples of nonnatural ligands that interact selectively with Bcl-2 proteins. Copyright © 2005 American Chemical Society.
引用
收藏
页码:1596 / 1597
页数:2
相关论文
共 33 条
[21]   A view to a kill: ligands for Bcl-2 family proteins [J].
Rutledge, SE ;
Chin, JW ;
Schepartz, A .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) :479-485
[22]  
RUTLEGDGE SE, 2003, THESIS YALE U NEW HA
[23]   Structure of Bcl-x(L)-Bak peptide complex: Recognition between regulators of apoptosis [J].
Sattler, M ;
Liang, H ;
Nettesheim, D ;
Meadows, RP ;
Harlan, JE ;
Eberstadt, M ;
Yoon, HS ;
Shuker, SB ;
Chang, BS ;
Minn, AJ ;
Thompson, CB ;
Fesik, SW .
SCIENCE, 1997, 275 (5302) :983-986
[24]   Herpesvirus protease inhibition by dimer disruption [J].
Shimba, N ;
Nomura, AM ;
Marnett, AB ;
Craik, CS .
JOURNAL OF VIROLOGY, 2004, 78 (12) :6657-6665
[25]   Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death [J].
Simonian, PL ;
Grillot, DAM ;
Nunez, G .
BLOOD, 1997, 90 (03) :1208-1216
[26]   From knowing to controlling: A path from Genomics to drugs using small molecule probes [J].
Strausberg, RL ;
Schreiber, SL .
SCIENCE, 2003, 300 (5617) :294-295
[27]   Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3 [J].
Tzung, SP ;
Kim, KM ;
Basañez, G ;
Giedt, CD ;
Simon, J ;
Zimmerberg, J ;
Zhang, KYJ ;
Hockenbery, DM .
NATURE CELL BIOLOGY, 2001, 3 (02) :183-191
[28]   BCL-2-DEFICIENT MICE DEMONSTRATE FULMINANT LYMPHOID APOPTOSIS, POLYCYSTIC KIDNEYS, AND HYPOPIGMENTED HAIR [J].
VEIS, DJ ;
SORENSON, CM ;
SHUTTER, JR ;
KORSMEYER, SJ .
CELL, 1993, 75 (02) :229-240
[29]  
WALENSK YLD, 2003, SCIENCE, V305, P1466
[30]   Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells [J].
Wang, JL ;
Liu, DX ;
Zhang, ZJ ;
Shan, SM ;
Han, XB ;
Srinivasula, SM ;
Croce, CM ;
Alnemri, ES ;
Huang, ZW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7124-7129